iShares Nasdaq US Biotechnology UCITS ETF

The iShares Nasdaq US Biotechnology UCITS ETF is most frequently paired with high-growth thematic equities, particularly in the semiconductors, defense, and artificial intelligence sectors. In portfolios like 2ª Iteração and Ricardo, these assets occupy significant allocations ranging from 10 to 20 percent, serving as aggressive growth engines designed to capture sector-specific alpha. While these portfolios accept higher volatility to chase returns, the inclusion of 2B70 acts as a tactical hedge against broader market trends, leveraging the unique regulatory and innovation-driven cycles of the biotech industry to diversify away from standard broad-market index exposure.

EuroFolio members utilize 2B70 primarily as a surgical tool for sector concentration rather than a foundational core holding. The data shows a clear divide in strategy, where high-conviction portfolios like Ricardo allocate a substantial 15 percent to the asset to amplify growth, while conservative, globally diversified models like FINECO treat it as a marginal 1 percent satellite position to add niche exposure without compromising overall portfolio stability. This suggests that while 2B70 is valued for its potential to outperform in bull markets, its role is highly dependent on the user's risk appetite, shifting from a primary growth driver in concentrated portfolios to a minor tactical tilt in multi-asset, low-volatility strategies.